# Dr Mike Rogers

Director of Research and Innovation, Motor Neurone Disease Association

Mike is director of research and innovation at the Motor Neurone Disease Association.

Prior to joining the MND Association in January 2025, Mike worked at the National Institute for Health and Care Research (NIHR) for over eight years.

In his roles at NIHR, Mike was responsible for the development of a new global applied health funding programme, NIHR RIGHT.

He was also the lead for their joint funding activities with the Medical Research Council during the Covid-19 pandemic, for which he was awarded an MBE in the 2021 Queen's Birthday Honours.

Mike has previously worked for the Department of Health, Cancer Research UK and the Pirbright Institute.

He holds a BSc (Hons) from Sheffield and a PhD from Kent, both in microbiology.

Before leaving the lab he undertook post-doctoral work in microbiology at Queen Mary University of London, CABI Bioscience and Imperial College London.

Profile: https://experts.pressassociation.com/expert/76

Photo: https://expert-hub-media.pamedia.io/experthub/profile/profile-cRw8FAouP7ZsAH5Z1J1xFz.jpeg?w=1200&dpr=2

## Views

- [Drug breakthrough could ‘substantially slow progression’ of MND, scientists say](https://experts.pressassociation.com/expert/76/views/386dcb65d999eabf)